Sidley advised on the initial public offering (IPO) and H share listing of Concord Healthcare Group Co., Ltd. (HKEX: 2453) (Concord Healthcare Group) on the Main Board of the Hong Kong Stock Exchange (HKEX). The offering raised approximately HK$562.9 million (US$72.2 million). Sidley acted as Hong Kong and U.S. counsel for the joint sponsors China International Capital Corporation Hong Kong Securities Limited, Haitong International Capital Limited, and the underwriters.
Concord Healthcare Group is an oncology healthcare service provider in China. It serves both cancer patients through its self-owned medical institutions and third-party medical institutions through its medical equipment, software and related services. In its self-owned medical institutions, the company provides a full spectrum of oncology healthcare services to cancer patients, leveraging its multidisciplinary team specialists and diagnosis and treatment capabilities featuring precision radiation therapy.
The Sidley team was led by partners Meng Ding and Claudia Yu. Other team members included senior associate Kevin Chan, associates Maggie Bai and Yiming Chen, China advisor Junlang Chen, legal manager Lexie Lu, and senior legal assistants Iris Lao, Freddie Feng, Alice Liu and Luting Cui.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
